Purchase Order 36C26126P0688

Edwards Lifesciences LLC has been awarded a firm fixed-price purchase order valued at $204,000 by Veterans Integrated Service Network 21 (VISN 21), a component of the Department of Veterans Affairs, for prosthetics and heart implants to support cardiac care at the VA Palo Alto Health Care System. The contract, executed on April 29, 2026, with a completion date of May 29, 2026, carries no set-aside designation and represents a continuation of Edwards Lifesciences' established role as a primary supplier of advanced cardiovascular devices to the VA healthcare system. As a self-certified small disadvantaged business, Edwards Lifesciences specializes in transcatheter heart valve replacement systems, including SAPIEN 3 and SAPIEN 3 Ultra valves with RESILIA tissue technology, INSPIRIS aortic valves, PASCAL mitral valve repair systems, and related surgical implants critical to the VA's cardiac surgical programs.

This purchase order operates within the framework of Edwards Lifesciences' broader contracting relationship with VISN 21, which includes a five-year indefinite delivery contract valued at $6.5 million (effective January 1, 2026, through December 31, 2030) for surgical implant consignment services to the VA Palo Alto Health Care System. That primary indefinite delivery vehicle employs a consignment model enabling VISN 21 to maintain inventory of specialized cardiac devices and procure them on an as-needed basis, optimizing inventory management for products with short shelf lives. Together with an additional $950,000 indefinite delivery contract with VISN 15, Edwards Lifesciences maintains total ceiling values of $7.45 million across its key VA service network partnerships, establishing the company as an essential framework supplier of advanced cardiovascular technologies supporting veteran patient outcomes across multiple integrated service networks.